David Chiron

10PUBLICATIONS
34CO-AUTHORS
Cancer diagnosisHaematological tumoursCancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 04, 2026
The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development.

|Feb 19, 2026
CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Candice Madiot, Céline Bellanger, Christelle Dousset

|Aug 09, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts.

Chloé C Lefebvre, Philippine Giowachini, Jennifer Derrien

|Feb 06, 2025
VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target.

Ophélie Champion, Sophie Maïga, Chloé Antier

|Oct 09, 2024
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.

Romane Durand, Céline Bellanger, Géraldine Descamps

|Mar 29, 2024
Unraveling MCL biology to understand resistance and identify vulnerabilities.

Clémentine Sarkozy, Benoit Tessoulin, David Chiron

Pageof 2

Frequent Collaborators

5 joint publications

Catherine Pellat-Deceunynck

4 joint publications

Benoit Tessoulin

3 joint publications

Géraldine Descamps

3 joint publications

Patricia Gomez-Bougie